On this resident blog, PGY-2 SOT Dr. Hannah Roppo joins us from the University of Colorado Hospital to discuss a fresh off-the-press trial exploring conversion from calcineurin inhibitor to belatacept-based maintenance immunosuppression in renal transplant recipients. This blog was precepted by Dr. Barrett Crowther. PMID: 34706967